I am surprised by this, however there is some fair
Post# of 147673
I don’t think this is tied to a partnership or buy out deal that is pending.those deals have a way of leaking to a select few and the sp starts rising for seemingly no reason. That is not happening. I do think the door is wide open now for any offers, it could be Nader really had a very lofty expectation of not just a huge price tag but also other requirements for a deal. I think there must have been offers of all types that were never developed. It just seems impossible that this amount of data from fda trials stays off the radar of big pharma.
I have no idea what happens next but I am guessing there will be far less communication. I hope the removal of Nader means key people are more focused than ever on the development of this drug. I hope a real great partner come forward to really pick this up. No more fife funding Amarex screwups and carrots held in front of us.